US2008075795A1PendingUtilityA1
Method and composition for preventing and treating avian influenza in poultry
Est. expirySep 20, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61P 31/00A61K 36/82A61K 45/06A61K 31/353
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and composition for preventing and treating Avian Influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigalloatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin.
Claims
exact text as granted — not AI-modified1 . A method for preventing and treating Avian Influenza in a poultry, comprising a step of administering to said poultry an anti-avian influenza ingredient having a composition, containing polyphenolic, selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigalloatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin.
2 . The method, as recited in claim 1 , wherein said anti-avian influenza ingredient includes said composition in combination with a carrier.
3 . The method, as recited in claim 2 , wherein said anti-avian influenza ingredient contains 98.0% by weight of said carrier and 2.0% by weight of said composition.
4 . The method, as recited in claim 1 , wherein said polyphenolic is extracted from tealeaves.
5 . The method, as recited in claim 3 , wherein said polyphenolic is extracted from tealeaves.
6 . The method, as recited in claim 1 , wherein theaflavin (TF1), theaflavin-3 gallate (TF2a), theaflavin-3′-gallate (TF2b), theaflavin-3,3′-digallate (TF-3), thearubigin, gallic acid and tannic acid are extracted from black tea.
7 . The method, as recited in claim 3 , wherein theaflavin (TF1), theaflavin-3 gallate (TF2a), theaflavin-3′-gallate (TF2b), theaflavin-3,3′-digallate (TF-3), thearubigin, gallic acid and tannic acid are extracted from black tea.
8 . The method, as recited in claim 1 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigalloatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin are extracted in green tea.
9 . The method, as recited in claim 3 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigalloatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin are extracted in green tea.
10 . The method, as recited in claim 1 , wherein said anti-avian influenza ingredient is administered directly to poultry by ingestion.
11 . The method, as recited in claim 5 , wherein said anti-avian influenza ingredient is administered directly to poultry by ingestion.
12 . The method, as recited in claim 1 , wherein said anti-avian influenza ingredient is administered directly to poultry by inhalation.
13 . The method, as recited in claim 1 , wherein said anti-avian influenza ingredient is administered directly to poultry by inhalation.
14 . The method, as recited in claim 5 , wherein said anti-avian influenza ingredient is administered directly to poultry by inhalation.
15 . The method, as recited in claim 1 , wherein said anti-avian influenza ingredient is administered directly to poultry by injection.
16 . The method, as recited in claim 5 , wherein said anti-avian influenza ingredient is administered directly to poultry by injection.
17 . A medicament composition for preventing and treating Avian Influenza in a poultry, comprising an anti-avian influenza ingredient having a composition, containing polyphenolic, selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigalloatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin.
18 . The medicament composition, as recited in claim 17 , wherein said anti-avian influenza ingredient includes said composition in combination with a carrier.
19 . The medicament composition, as recited in claim 18 , wherein said anti-avian influenza ingredient contains 98.0% by weight of said carrier and 2.0% by weight of said composition.
20 . The medicament composition, as recited in claim 19 , wherein said polyphenolic is extracted from tealeaves.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.